From: Up-regulation of CNDP2 facilitates the proliferation of colon cancer
Variables | n (%) | CNDP2 expression | Pvalue | |
---|---|---|---|---|
Low | High | |||
Age — yr | Mean 57.5 | 56.2 ± 10.7 | 58.5 ± 9.5 | 0.894a |
Gender—n (%) | ||||
Male | 76 (50.7) | 29 (44.6) | 47 (55.3) | 0.195b |
Female | 74 (49.3) | 36 (55.4) | 38 (44.7) | |
Tumour size —n (%) | ||||
≤ 5 cm | 44 (29.3) | 22 (33.3) | 22 (26.2) | 0.340b |
> 5 cm | 106 (70.7) | 44 (66.7) | 62 (73.8) | |
Lymph nodes metastasis—n (%) | ||||
No | 76 (50.7) | 38 (57.6) | 38 (45.2) | 0.134b |
Yes | 74 (49.3) | 28 (42.4) | 46 (54.8) | |
Tumour grade—n (%) | ||||
1 | 20 (21.5) | 8 (32.4) | 12 (7.1) | 0.434b |
2 | 106 (53.9) | 50 (46.0) | 56 (64.3) | |
3 | 24 (24.6) | 8 (21.6) | 16 (28.6) | |
Tumor stage—n (%) | ||||
I | 24 (16.0) | 12 (18.2) | 12 (14.2) | 0.927b |
II | 46 (30.7) | 20 (30.3) | 26 (31.0) | |
III | 62 (41.3) | 26 (39.4) | 36 (42.9) | |
IV | 18 (12.0) | 8 (12.1) | 10 (11.9) | |
CEA—n (%) | ||||
Negative | 96 (64.0) | 44 (63.8) | 52 (64.2) | 0.956b |
Positive | 54 (36.0) | 25 (36.2) | 29 (35.8) | |
Tumor location—n (%) | ||||
RCC | 84 (56.0) | 28 (42.4) | 56 (66.7) | 0.003b* |
LCC | 66 (44.0) | 38 (57.6) | 28 (33.3) | |
RCC—n (%) | ||||
Male | 42 (50.0) | 9 (33.3) | 33 (57.9) | 0.035b* |
Female | 42 (50.0) | 18 (66.7) | 24 (42.1) | |
LCC—n (%) | ||||
Male | 34 (51.5) | 20 (52.6) | 14 (50.0) | 0.833b |
Female | 32 (48.5) | 18 (47.4) | 14 (50.0) |